The nation of Zimbabwe has declined a significant American health deal worth 367 million US dollars (272 million pounds) spanning five years over Washington's insistence on confidential information.
This move became public following a government memo from December was disclosed, which showed Head of State Emmerson Mnangagwa deemed the deal was "unbalanced".
A government representative has since clarified that the US was demanding access to biological samples for scientific study and commercial purposes while was unwilling to share the benefits from any future treatments.
"We are forced to start the challenging and unfortunate process of ending our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had donated more than $1.9bn in health funding to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has urged continued negotiations to reach a agreement acceptable to both sides so the nation's vital HIV programme can continue.
Wider Context
This rejection comes after a comparable situation in neighbouring Kenya, where a high court blocked a related deal with the US following concerns were filed about the safety of citizens' health data.
Since returning to the presidency last year, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
USAID had administered assistance for the US government, but Trump argued its expenditure was "inefficient" and his administration was pursuing government-to-government agreements to enhance openness and responsibility.
As per reports, Sixteen African countries have to date signed similar health pacts, constituting over $18.3bn of fresh investment.
Specifics of the Rejected Deal
The money for Zimbabwe was intended to funded "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this collaboration might have yielded immense advantages for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving HIV treatment via US-supported programmes," the Ambassador commented.
However, official spokesman Nick Mangwana maintained the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to surrender its genetic material and health information for a long time, with no equivalent guarantee of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.
"Put simply, our nation would provide the basic resources for medical research with no assurance that the resulting innovations would be accessible to our citizens should a new disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further said that the American exit from the global health body and its pursuit of bilateral deals were upending structures already set up via the global health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing framework created to manage future global health emergencies.
"This mechanism is intended to guarantee that when a country contributes its data, the benefits – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to create them."
The government's concerns over the US deal "are not meant as opposition to America," he added.
"We welcome continued dialogue with our American counterparts on how future collaboration could be designed in a way that respects the independence and dignity of both nations."
Health Experts Reaction
Medical experts stated it recognised the government's concerns, but recommended that talks must proceed given that a large portion of the nation's HIV programmes relied on foreign aid.
"In cases where specific concerns exist, such as those involving information security or implementation frameworks, these can often be addressed through detailed discussion and negotiated safeguards," the group added.
The situation highlights the ongoing tensions between receiving much-needed foreign assistance and safeguarding a country's data in an ever more data-driven world.